Targeting oxidative distress to treat chemobrain: Go with the choroid plexus-cerebrospinal fluid flow

Abstract

Chemobrain is a variable but debilitating consequence of lifesaving cancer treatments. In this issue of Neuron, Jang and colleagues provide a new conceptual framework based on choroid plexus-CSF antioxidant status that advances understanding of chemobrain's nervous system pathobiology and identifies novel therapeutic opportunities.